Abstract
In many countries with low tuberculosis (TB) incidence (<10/100,000) a high proportion of cases originate from latent TB infection (LTBI) reactivation among migrants from high-incidence countries (≥100/100,000) who have been infected before arrival in the host country [1, 2]. Consequently, LTBI screening and management for migrants is an important intervention to reduce TB incidence in those countries [1, 3, 4].
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Mrs. Nederby Öhd has nothing to disclose.
Conflict of interest: Dr. Hergens has nothing to disclose.
Conflict of interest: Dr. Luksha has nothing to disclose.
Conflict of interest: Dr. Buxbaum has nothing to disclose.
Conflict of interest: Dr. shedrawy has nothing to disclose.
Conflict of interest: Dr. Jonsson has nothing to disclose.
Conflict of interest: Dr. Bruchfeld has nothing to disclose.
Conflict of interest: Dr. Lönnroth has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received February 26, 2020.
- Accepted August 12, 2020.
- Copyright ©ERS 2020
This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
